Phichayut Phinyo

Dr. Phichayut Phinyo

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2022 in Cancers
Verified
Journal Article
Open access
PDF file
SOSanthasiri Orrapin
Santhasiri Orrapin
SUSasimol Udomruk
Sasimol Udomruk
WLWorakitti Lapisatepun
Worakitti Lapisatepun
SMsutpirat moonmuang
sutpirat moonmuang
APAreerak Phanphaisarn
Areerak Phanphaisarn
PCParunya Chaiyawat
Parunya Chaiyawat
Circulating tumor cells (CTCs) play a key role in hematogenous metastasis and post-surgery recurrence. In hepatocellular carcinoma (HCC), CTCs have emerged as a valuable source of therapeutically relevant information. Certain subsets or phenotypes of CTCs can survive in the bloodstream and induce metastasis. Here, we performed a systematic review on the importance of epithelial–mesenchymal transition (EMT)-CTCs and circulating cancer stem cells (CCSCs) in metastatic processes and their prognostic power in HCC management. PubMed, Scopus, and Embase databases were searched for relevant publications. PRISMA criteria were used to review all studies. Twenty publications were eligible, of which 14, 5, and 1 study reported EMT-CTCs, CCSCs, and both phenotypes, respectively. Most studies evaluated that mesenchymal CTCs and CCSCs positivity were statistically associated with extensive clinicopathological features, including larger size and multiple numbers of tumors, advanced stages, micro/macrovascular invasion, and metastatic/recurrent disease. A preliminary meta-analysis showed that the presence of mesenchymal CTCs in pre- and postoperative blood significantly increased the risk of early recurrence. Mesenchymal-CTCs positivity was the most reported association with inferior outcomes based on the prognosis of HCC recurrence. Our finding could be a step forward, conveying additional prognostic values of CTC subtypes as promising biomarkers in HCC management.

7 March 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Suwatthanachai PhomprasithSuwatthanachai Phomprasith
Suwatthanachai Phomprasith
NKNuntaporn Karawekpanyawong
Nuntaporn Karawekpanyawong
KPKanokporn Pinyopornpanish
Kanokporn Pinyopornpanish
WJWichuda Jiraporncharoen
Wichuda Jiraporncharoen
BMBenchalak Maneeton
Benchalak Maneeton
Suppachai LawanaskolSuppachai Lawanaskol
Suppachai Lawanaskol
This study was conducted to investigate the prevalence and associated factors of depression in medical students. This cross-sectional study investigated the prevalence and associated factors of depression in medical students from May 2018 to April 2019. Depression was diagnosed using the nine-item Patient Health Questionnaire. We evaluated the following potential predictors: demographic data, stressors, psychiatric comorbidities, emotional intelligence (EI), and perceived social support. The association between potential factors and depression was analyzed using multiple logistic regression analysis. The prevalence of depression was 149 of 706 students with 12.5% suicidality. Second- and fourth-year medical students were high-risk groups. Risk factors identified were insufficient income, physical illness, and previous psychiatric illness. Depression in medical students likely coincides with anxiety, internet addiction, sleep problems, and loneliness. Highly associated stressors were personal relationships, physical health, mental health, difficulties in social relationships, satisfaction with grades, and boredom with medical education. Protective EI factors included emotional self-control, problem-solving abilities, inner peace, and life satisfaction. Up to 21.1% of medical students had depression. In this study, among multiple known risk factors of depression, we found that EI is the novel protective factor against depression among medical students. EI training might be protective intervention for medical students in the future.

1 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
APAdchara Prommaban
Adchara Prommaban
SMSasiwimon Moonkayaow
Sasiwimon Moonkayaow
PPPhichayut Phinyo
Phichayut Phinyo
Penprapa SivirojPenprapa Siviroj
Penprapa Siviroj
Wachiranun SirikulWachiranun Sirikul
Wachiranun Sirikul
PLPeerasak Lerttrakarnnon
Peerasak Lerttrakarnnon
Background: Frailty is characterized by the decreased ability in older adults to handle daily or acute stressors due to age-related declines in physiological reserve and organ system performance. This condition results from the interaction of multiple physiological pathways and changes in biomarkers. Exercise programs are currently recommended to promote “healthy aging” in frail older adults. Objective: This systematic review aimed to evaluate the effectiveness of exercise program interventions in improving outcomes related to frailty, physical function, cognitive performance, and biomarkers in frail older adults. Methods: This study was designed according to the PRISMA guidelines. A systematic search was conducted in PubMed, Embase, and Scopus for studies published between 2014 and 2024. Two independent reviewers extracted data, with disagreements resolved by a third reviewer. Randomized controlled trials involving pre-frail or frail older adults aged 60 and above in all settings were included. The focus was on the impact of exercise programs, especially multicomponent interventions, on frailty outcomes and biomarkers. Results: Nine studies involving a total of 2083 participants met the inclusion criteria. The age range of participants was 65.35 ± 5.15 to 86.7 ± 4.00 years, with 64.7% being female. The results demonstrated that multicomponent exercise programs significantly improved frailty status, enhanced physical and cognitive function, and improved emotional well-being. Additionally, these programs led to significant reductions in inflammatory biomarkers, such as IL-6 and TNF-α, which are associated with frailty. Conclusion: This review highlights the beneficial effects of multicomponent exercise programs on pre-frail and frail older adults, providing evidence that these interventions improve physical and cognitive functions and emotional well-being, and reduce inflammation. These findings offer valuable insights into developing targeted interventions to manage frailty in clinical practice.

1 February 2022 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
WMWorapaka Manosroi
Worapaka Manosroi
PAPichitchai Atthakomol
Pichitchai Atthakomol
NINatthanaphop Isaradech
Natthanaphop Isaradech
PPPhichayut Phinyo
Phichayut Phinyo
TVTanawat Vaseenon
Tanawat Vaseenon
Purpose: Osteoporotic hip fracture surgery is associated with a risk of morbidity and mortality. Admission hemoglobin levels < 10 g/dL have been documented as a strong predictor of mortality risk. This study aimed to investigate the mortality outcome between osteoporotic hip fracture patients who had preoperative hemoglobin levels raised to ≥ 10 g/dL and those with hemoglobin levels were < 10 g/dL. Patients and Methods: This 5-year retrospective observational study included 226 participants with osteoporotic hip fractures that required surgery and who had admission hemoglobin levels < 10 g/dL. Patients were categorized into two groups: those with corrected preoperative hemoglobin ≥ 10 g/dL and those with either corrected or uncorrected preoperative hemoglobin < 10 g/dL. Outcomes were analyzed using Cox proportional hazard regression adjusted for confounders. Results are presented as hazard ratio (HR) and 95% confidence interval (95% CI). Results: Among 226 the patients, the overall mortality rate was 17.25% (n=39/226) of the 226 patients, 93 (41.15%) had their hemoglobin levels raised to ≥ 10 g/dL by red blood cell transfusion. Multivariable analysis after adjustment for confounders showed a 50% lower incidence of mortality among patients with preoperative hemoglobin levels ≥ 10 g/dL than among those with hemoglobin levels < 10 g/dL (HR 0.50, 95% CI (0.25– 0.99), p=0.048). Conclusion: In osteoporotic hip fracture patients with admission hemoglobin < 10g/dL, raising preoperative hemoglobin levels to ≥ 10 g/dL can significantly reduce the risk of mortality. Testing for and correction of low preoperative hemoglobin levels is of value in hip surgery patients.

1 August 2020 in Complementary Therapies in Clinical Practice
Verified
Journal Article
Closed access
PRPatchara Ruengwongroj
Patchara Ruengwongroj
SMSombat Muengtaweepongsa
Sombat Muengtaweepongsa
JPJayanton Patumanond
Jayanton Patumanond
PPPhichayut Phinyo
Phichayut Phinyo

21 October 2021 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
SKSalin Kiratikanon
Salin Kiratikanon
PPPhichayut Phinyo
Phichayut Phinyo
RRRujira Rujiwetpongstorn
Rujira Rujiwetpongstorn
JPJayanton Patumanond
Jayanton Patumanond
VTVeeraphol Tungphaisal
Veeraphol Tungphaisal
MCMati Chuamanochan
Mati Chuamanochan